Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 398

1.

Dried Leaf Artemisia Annua Improves Bioavailability of Artemisinin via Cytochrome P450 Inhibition and Enhances Artemisinin Efficacy Downstream.

Desrosiers MR, Mittelman A, Weathers PJ.

Biomolecules. 2020 Feb 7;10(2). pii: E254. doi: 10.3390/biom10020254.

2.

Rate of Programs Affected by Resident Attrition and Program Factors Associated With Attrition in Emergency Medicine.

Brockberg M, Mittelman A, Dugas J, McCabe K, Spector J, Liu J, Sheng AY.

J Grad Med Educ. 2019 Dec;11(6):663-667. doi: 10.4300/JGME-D-19-00248.1.

PMID:
31871566
3.

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.

Bednarczyk RB, Tuli NY, Hanly EK, Rahoma GB, Maniyar R, Mittelman A, Geliebter J, Tiwari RK.

Oncotarget. 2018 Mar 23;9(36):24272-24282. doi: 10.18632/oncotarget.24917. eCollection 2018 May 11.

4.

Comment on "A re-assessment of the safety of silver in household water treatment: rapid systematic review of mammalian in vivo genotoxicity studies".

Lantagne D, Rayner J, Mittelman A, Pennell K.

Environ Health. 2017 Nov 13;16(1):121. doi: 10.1186/s12940-017-0334-1.

5.

Neurocognitive function in paediatric obsessive-compulsive disorder.

Geller DA, Abramovitch A, Mittelman A, Stark A, Ramsey K, Cooperman A, Baer L, Stewart SE.

World J Biol Psychiatry. 2018 Mar;19(2):142-151. doi: 10.1080/15622975.2017.1282173. Epub 2017 Feb 14.

6.

NEUROPSYCHOLOGICAL PREDICTORS OF TREATMENT RESPONSE TO COGNITIVE BEHAVIORAL GROUP THERAPY IN OBSESSIVE-COMPULSIVE DISORDER.

Braga DT, Abramovitch A, Fontenelle LF, Ferrão YA, Gomes JB, Vivan AS, Ecker KK, Bortoncello CF, Mittelman A, Miguel EC, Trentini CM, Cordioli AV.

Depress Anxiety. 2016 Sep;33(9):848-61. doi: 10.1002/da.22509. Epub 2016 Apr 21.

PMID:
27100799
7.

Comorbidity Between Attention Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder Across the Lifespan: A Systematic and Critical Review.

Abramovitch A, Dar R, Mittelman A, Wilhelm S.

Harv Rev Psychiatry. 2015 Jul-Aug;23(4):245-62. doi: 10.1097/HRP.0000000000000050. Review.

8.

Neuropsychological investigations in obsessive-compulsive disorder: A systematic review of methodological challenges.

Abramovitch A, Mittelman A, Tankersley AP, Abramowitz JS, Schweiger A.

Psychiatry Res. 2015 Jul 30;228(1):112-20. doi: 10.1016/j.psychres.2015.04.025. Epub 2015 Apr 30. Review.

PMID:
25957648
9.

Research Review: Neuropsychological test performance in pediatric obsessive-compulsive disorder--a meta-analysis.

Abramovitch A, Abramowitz JS, Mittelman A, Stark A, Ramsey K, Geller DA.

J Child Psychol Psychiatry. 2015 Aug;56(8):837-47. doi: 10.1111/jcpp.12414. Epub 2015 Apr 13.

PMID:
25866081
10.

The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

Sulkowski ML, Geller DA, Lewin AB, Murphy TK, Mittelman A, Brown A, Storch EA.

Curr Psychiatry Rev. 2014;10(4):317-324.

11.

The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis.

Abramovitch A, Abramowitz JS, Mittelman A.

Clin Psychol Rev. 2013 Dec;33(8):1163-71. doi: 10.1016/j.cpr.2013.09.004. Epub 2013 Sep 29.

PMID:
24128603
12.

Mathematical modeling of the transport and dissolution of citrate-stabilized silver nanoparticles in porous media.

Taghavy A, Mittelman A, Wang Y, Pennell KD, Abriola LM.

Environ Sci Technol. 2013 Aug 6;47(15):8499-507. doi: 10.1021/es400692r. Epub 2013 Jul 19.

PMID:
23819811
13.

Getting to the heart of influenza.

Yewdell JW, Spiro DJ, Golding H, Quill H, Mittelman A, Nabel GJ.

Sci Transl Med. 2013 Jun 26;5(191):191ed8. doi: 10.1126/scitranslmed.3006735. No abstract available.

14.

Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA.

Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

15.

Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.

Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK.

PLoS One. 2012;7(2):e30839. doi: 10.1371/journal.pone.0030839. Epub 2012 Feb 20.

16.

Endothelial progenitor cell biology in disease and tissue regeneration.

George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK.

J Hematol Oncol. 2011 May 24;4:24. doi: 10.1186/1756-8722-4-24. Review.

17.

Identification of PSA peptide mimotopes using phage display peptide library.

Shanmugam A, Suriano R, Chaudhuri D, Rajoria S, George A, Mittelman A, Tiwari RK.

Peptides. 2011 Jun;32(6):1097-102. doi: 10.1016/j.peptides.2011.04.018. Epub 2011 Apr 22.

PMID:
21539876
18.

Identification of peptide mimotopes of gp96 using single-chain antibody library.

Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, Rajoria S, George AL, Mittelman A, Tiwari RK.

Cell Stress Chaperones. 2011 Mar;16(2):225-34. doi: 10.1007/s12192-010-0234-6. Epub 2010 Oct 16.

19.

Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions.

Suriano R, Ghosh SK, Chaudhuri D, Mittelman A, Banerjee A, Tiwari RK.

Glycobiology. 2009 Dec;19(12):1427-35. doi: 10.1093/glycob/cwp096. Epub 2009 Jul 3.

PMID:
19578160
20.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949

Supplemental Content

Loading ...
Support Center